Research Analysts Set Expectations for Vitalhub Q1 Earnings

Key Points

• Roth Capital raised its Q1 2026 earnings per share estimate for Vitalhub from $0.05 to $0.06, while also projecting Q3 2026 earnings at $0.07 EPS and full-year FY2026 earnings at $0.28 EPS.
• Vitalhub's stock recently traded down by 4.8%, reaching C$12.68, with a market capitalization of C$685.89 million and a P/E ratio of 206.24.
• Several analysts have upgraded their ratings and price targets for Vitalhub, with six analysts giving the stock a buy rating and one a strong buy, resulting in a consensus rating of "Buy."

Vitalhub Corp. (TSE:VHI - Free Report) - Analysts at Roth Capital lifted their Q1 2026 earnings per share (EPS) estimates for Vitalhub in a research report issued to clients and investors on Monday, August 11th. Roth Capital analyst R. Baldry now forecasts that the company will post earnings of $0.06 per share for the quarter, up from their previous forecast of $0.05. The consensus estimate for Vitalhub's current full-year earnings is $0.23 per share. Roth Capital also issued estimates for Vitalhub's Q3 2026 earnings at $0.07 EPS and FY2026 earnings at $0.28 EPS.

Several other analysts have also recently issued reports on VHI. Raymond James Financial upped their target price on Vitalhub from C$14.50 to C$15.00 and gave the company an "outperform" rating in a report on Tuesday. National Bank Financial raised Vitalhub to a "strong-buy" rating in a research note on Monday, June 9th. TD Securities increased their price target on Vitalhub from C$15.00 to C$16.00 and gave the company a "buy" rating in a research report on Monday. Scotiabank increased their price target on Vitalhub from C$14.00 to C$14.50 and gave the company an "outperform" rating in a research report on Friday, June 20th. Finally, National Bankshares set a C$14.00 target price on Vitalhub and gave the stock an "outperform" rating in a research report on Tuesday, June 10th. Six investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Buy" and an average price target of C$13.75.

Vitalhub Stock Down 4.8%

Shares of Vitalhub stock traded down C$0.64 on Thursday, reaching C$12.68. The company's stock had a trading volume of 334,653 shares, compared to its average volume of 144,685. The company has a market capitalization of C$685.89 million, a P/E ratio of 206.24, a PEG ratio of 1.18 and a beta of 1.26. Vitalhub has a 52-week low of C$7.62 and a 52-week high of C$14.64. The stock has a 50-day moving average price of C$12.04 and a 200-day moving average price of C$10.91.

Insider Transactions at Vitalhub

In related news, Director Francis Nelson Shen bought 25,000 shares of the firm's stock in a transaction dated Friday, May 16th. The stock was bought at an average price of C$10.23 per share, with a total value of C$255,750.00. Company insiders own 18.57% of the company's stock.

Vitalhub Company Profile

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.